New Genome Study of B. longum subsp. longum by Morinaga Milk May Explain the Species' Wide Distribution across All Ages
Bifidobacterium longum is one of only a handful of species of gut bacteria that is widely present among people of all ages, including infants, adults and the elderly.1,2 Today, Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading Japanese dairy product company, announced the results of a groundbreaking new genome study, in collaboration with the SFI Research Centre APC Microbiome Ireland, that may explain why.
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180214005461/en/
(Fig.1) Distribution of gut microbiota in healthy Japanese subjects (Graphic: Business Wire)
The human gut is colonized by a collection of microbes (microbiome) which play an integral role in human health, by helping us digest our food, produce certain vitamins, regulate our immune system, and protect us against pathogenic bacteria. This current study revealed that one bacterial species, B. longum subsp. longum, demonstrates a wide variation in its genes that increases its competitiveness in the gut environment, because its genome adapts to the changing diet of each generation. In addition, it suggests that B. longum subsp. longum is extensively transmitted between relatives, and that such transmission does not occur only between mothers and infants, as previously believed, but also between other family members and even across three generations.3
Study Overview
For the study, a total of 453 fecal
samples were collected from healthy Japanese subjects aged 0 to 104
years, as a means of measuring the bacterial species present in the gut.
In total, 871 different bacterial species were detected (Fig.1), but
only three species (Blautia wexlerae, Streptococcus salivarius
and Bifidobacterium longum) were found to be present in more than
50% of the subjects across all generations.
This finding highlights the broad distribution of B. longum across the human lifespan. In order to identify the mechanism that allows a specific species to be so ubiquitous, Morinaga, in collaboration with the SFI Research Centre APC Microbiome Ireland at the National University of Ireland, Cork, performed a comparative genome analysis on various strains of B. longum subsp. longum to determine genetic differences among strains isolated from people of varying ages.
B. longum
subsp. longum Strains Separated into Seven
Clusters
Comparative analyses involving 145 B. longum
representatives obtained from Japanese subjects, including 32 publicly
available genomes, showed that B. longum subsp. longum
strains can be grouped into seven clusters depending on the presence of
prophage (i.e. viral material) and/or a megaplasmid (i.e. genetic
material being present outside of the bacterial chromosome).
No correlation was observed between isolated strains and subject age, although a significant negative correlation was found between the number of identified genes present in the strains and subject age. This suggests that B. longum subsp. longum strains isolated from younger subjects possess, on average, a higher number of genes compared to the ones from older subjects. Researchers performed further investigation to identify genes in each strain isolated from different age groups, and as a result, gene families were classified into four groups: infant, adult, elderly-predominant gene families, and genes that exhibit no relationship with subjects age (Fig.2).
Infant-associated Strains More Adapted to Utilize Carbohydrates
Found in Human Milk
Researchers frequently found strains in B.
longum subsp. longum from younger subjects, which possess
genetic code that is related to sugar utilization, including that of the
sugar sialic acid which is one of the components of Human Milk
Oligosaccharides (HMOs) that are found in breast milk. This
characteristic may be an adaptive strategy of B. longum to
survive the infant gut environment by utilizing components from the
mother’s breast milk.
Elderly-associated Strains More Adapted to Utilize Insoluble Fiber
Found in Vegetables
Researchers also observed a high number
of strains in B. longum subsp. longum isolated from
elderly subjects that contain unique genetic information thought to
encode extracellular α-L-arabinofuranosidases (Arabinofuranosidase
cluster2 in Fig.2). These enzymes are able to break down complex sugars
that are present in plant material, such as vegetables and cereals, all
of which contain a high proportion of insoluble fiber. Elderly Japanese
people are reported to eat much more vegetables than younger people4,
so this genetic trait to digest fiber-containing foods may allow B.
longum to persist in the elderly gut.
In addition, two clusters of genes indicative of how bacteria respond to environmental stress were found in higher numbers among strains of B. longum subsp. longum isolated from elderly subjects, including the heat shock protein HSP20.5 Heat shock proteins are produced to help an organism respond to stress, such as extreme heat, oxygen exposure and starvation. It is reasonable to assume that strains with the ability to respond to stress are better able to adapt and survive.
Certain Strains Have Been Transmitted Between Father and Child,
Husband and Wife, and Even Across Three Generations
Several B.
longum subsp. longum strains, which had been isolated from
many different members of the same family, were shown to contain an
essentially identical genetic content. This finding suggests that these
strains had been transmitted between various family members, not only
between mother and child, which has been previously reported.6
“It is a remarkable finding that not only was transmission between mother and child observed, but also between father and child and even between husband and wife,” stated Dr. Toshitaka Odamaki, Manager of Microbiota Research Dept. at Next Generation Science Institute of Morinaga and lead researcher of the study. “This is also the first report of a particular strain of gut microbiota that appears to have been transmitted across three generations in a family, for instance, between a grandmother, mother, and infant,” he added.
“We assume this variety of genes and high transfer level of the bacterial species within families is the survival strategy of B. longum subsp. longum and is key to its wide distribution across the human lifespan,” explained Dr. Odamaki. “This report could provide a promising foundation for future research aimed at identifying the best probiotic candidates at each key life stage,” he continued.
“APC Microbiome Ireland is very interested in how the human microbiota changes over the life stages, in response to exposure to different environmental factors such as habitual diet, antibiotic exposure, and levels of stress”, said Prof Douwe van Sinderen, project leader at APC Microbiome Ireland. He furthermore emphasized the attraction of such a joint scientific effort: “This was a particularly fruitful and gratifying collaborative project with an industry partner, Morinaga, because we were able to join our complementary skills and know-how allowing us to generate insights that we would otherwise not have been able to obtain on our own”.
Dr. Odamaki from Morinaga discussed these findings at the IPA World Congress + Probiota Barcelona held in Barcelona, Spain on February 7th -9th, 2018.
About Morinaga
Morinaga Milk Industry Co., Ltd. is
one of the leading dairy product companies in Japan. Morinaga started
research on bifidobacteria in the 1960s, inspired by the fact that
bifidobacteria are the predominant bacteria residing in the intestines
of breast-fed infants. In 1969, Morinaga isolated its flagship strain Bifidobacterium
longum BB536 from an infant. Morinaga excels in innovative
technology and offers various dairy products and other beneficial
functional ingredients to customers around the world.
ABOUT APC MICROBIOME IRELAND
APC Microbiome Ireland
(APC; http://apc.ucc.ie)
is a world leading research institute which was formed in 2003 with
funding from Science Foundation Ireland and in conjunction with key
industry partners. It represents a seamless collaboration between
University College Cork and Teagasc (the Irish Agriculture and Food
Development Authority).It is widely recognised that the gut microbiota
plays an important role in human health and has become one of the most
dynamic, complex and exciting areas of research in both food and
pharmaceutical arenas. Over the last decade the APC has established
itself as one of the leading global centres in gut microbiota research.
The APC has made several landmark discoveries and has published over
1,700 research articles in peer-reviewed journals, generating many
journal covers and associated editorials. The APC comprises over 300
individuals, from the scientific Principal Investigators (the APC
Faculty) funded by the partner Institutions, the management team, and a
dedicated group of research scientists, research assistants and
postgraduate students.
References | ||
1. |
Turroni et al., Applied and environmental microbiology (2009) |
|
2. |
Francoise Gavini, Microb. Ecol. Health Dis (2001) |
|
3. |
Odamaki et al., Scientific Reports (2018) |
|
4. | National Health and Nutrition Survey 2015 | |
5. |
Ventura et al., Appl. Environ. Microbiol (2007) |
|
6. |
Makino et al., Appl. Environ. Microbiol (2011) |
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180214005461/en/
Contact information
Morinaga Milk Industry Co., Ltd.
Mai Nozawa, +81-3-3798-0152
m-nozawa@morinagamilk.co.jp
http://www.morinagamilk.co.jp/english/
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
LabPMM ® Receives New York State Approval for the NPM1 MRD Assay - Informing Therapy and Accelerating Targeted Trials18.6.2025 07:30:00 EEST | Press release
Invivoscribe is happy to announce that its wholly owned subsidiary, the Laboratory for Personalized Molecular Medicine® (LabPMM) has received approval from New York State (NYS) for the NPM1 MRD Assay. This approval comes just two months after gaining NYS approval for our FLT3 ITD MRD Assay. Together these tests represent a critical tool for patients with acute myeloid leukemia (AML), clinicians and pharmaceutical companies. This new approval underscores Invivoscribe’s ongoing commitment to providing the most accurate, standardized measurable residual disease (MRD) testing solutions worldwide. The NPM1 MRD Assay is a pivotal development in the fight against AML, offering an ultra-sensitive DNA sequencing method to accurately measure trace levels of residual leukemia cells in patients with the NPM1 mutation variants. NPM1 mutations are considered an ideal target for MRD assessment because they are present in ~30% of adult AML cases,1 stable over time,2 and, if present in blood at allele
DNP to Take Controlling-Stake in Laxton18.6.2025 04:30:00 EEST | Press release
Dai Nippon Printing Co., Ltd. (DNP, TOKYO: 7912) entered into a share transfer agreement on June 17, 2025 to acquire Cayman Islands-headquartered Rubicon SEZC. Rubicon (a holding company of “Laxton” group) is a global Identity Systems Integrator that provides ID solutions for governments, primarily in developing nations, to register and authenticate personal information. DNP plans to acquire 75% of Rubicon's shares in July and complete the procedures to make the company a Group company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250613922077/en/ Products of Laxton DNP will maximize synergies with Laxton in ID cards and card printers. By expanding to government-related business in Africa, Asia, South America, and other regions, we will further grow our authentication and security business, contributing to a safe and secure Smart Society. [About Laxton] Laxton develops ID authentication services using biometric information
DNP: Operational Launch of 2,500 mm-Width Coating Line to Enhance Production Capacity by 15%18.6.2025 04:20:00 EEST | Press release
Dai Nippon Printing Co., Ltd. (DNP) is pleased to announce the September operational launch of a coating device compatible with 2,500 mm-width high functional optical film at our Mihara Plant in Hiroshima Prefecture. The operational launch of the second wide coating device comes in response to market and consumer needs, and will boost production capacity by more than 15% on an area basis. With the increased capacity, DNP will accommodate the demand for high functional optical film for 65-inch large-screen TVs, with horizontal and vertical dimensions of 1,436.4 mm x 809.0 mm, which are expected to increase at a compound annual growth rate (CAGR) of approximately 6% between 2025 and 20301 on an area basis. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250613720341/en/ Image of Mihara Plant [Features] Facilitates the efficient manufacture, or imposition, of high function optical film for 65 inch large screen displays. Designed
Alipay Enables In-Store Payment Functionality in China for AR Glasses in Collaboration with Rokid to Build Immersive Commerce18.6.2025 03:27:00 EEST | Press release
Rokid, a pioneer in augmented reality (AR), today launched Rokid Glasses, its latest AR device. In China, the product supports in-store payments facilitated by Alipay’s digital payment technology and multidimensional risk control solution for AR glasses, providing a seamless and secure payment experience. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250617845457/en/ Rokid partners with Alipay to launch China’s first AR glasses with in-store payment capabilities. According to Rokid, the product will begin rolling out to users starting in June 2025, with over 250,000 units already ordered. How Payment via AR Glasses Works: Users link their Alipay account via the Rokid app and enable voice verification. In stores, they say: “Rokid, pay 10 RMB.” The glasses scan the merchant’s Alipay QR code. Users confirm by voice, with payment details shown on the display. Advantages of Payment via AR Glasses: Transactions complete in second
SES Successfully Prices €1 Billion Dual-Tranche Bond Offering with Strong 5.5x Oversubscription17.6.2025 23:25:00 EEST | Press release
NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA (THE UNITED STATES), OR TO ANY US PERSON (AS DEFINED IN REGULATION S UNDER THE U.S. SECURITIES ACT OF 1933), OR IN OR INTO ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT. SES S.A. today announced the successful launch and pricing of a dual-tranche note offering in which the company has agreed to sell senior unsecured fixed rate notes under its €5,500,000,000 EMTN Programme (the "Notes"). Settlement is expected to take place on 24 June 2025: EUR 500 million of Notes will bear a coupon of 4.125% due in 2030. EUR 500 million of Notes will bear a coupon of 4.875% due in 2033. SES is rated Baa3, negative outlook by Moody’s and BBB, negative outlook by Fitch. SES shall apply the net proceeds of the Notes towards its general corporate purposes, including, without limitation (i) financ
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom